Tubitere Novo 20mg Injection
Marketer
Alkem Laboratories Ltd
Salt Composition
Docetaxel (20mg)
Overview Tubitere Novo 20mg Injection
Oncaspar 20mg Injection is a chemotherapy agent indicated for breast cancer, non-small cell lung cancer, prostate cancer, and head and neck cancers. Administration is strictly via injection by a healthcare professional. Dosage and frequency are determined by your physician, varying based on your specific condition and potentially adjusted over time. Adhere precisely to your physician's instructions; improper use or overdose can lead to severe adverse reactions. Therapeutic effects may not be apparent for weeks or months; discontinue use only under your doctor's guidance. Common side effects may include shortness of breath, constipation, swelling, infection, decreased appetite, myalgia, nail abnormalities, pain, and fatigue. Supplementary medications may be prescribed to mitigate these effects. Report unexplained bleeding or bruising, sore throat, mouth sores, or fever to your doctor immediately. This medication can lower blood cell counts (red and white blood cells), increasing infection risk. Regular blood tests to monitor blood cell levels and liver function are necessary. Inform your doctor of any pre-existing heart, liver, or kidney conditions, or concurrent use of anti-infective medications, before commencing treatment. Interactions with other medications are possible; disclose all current medications to your physician. This medication is contraindicated during pregnancy and breastfeeding. Reliable contraception is crucial for both partners throughout the treatment period to prevent conception.
Uses of Tubitere Novo 20mg Injection
Cancers of the breast, lung (non-small cell), prostate, and head and neck.
Major Benefits of Tubitere Novo 20mg Injection:
The medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
Common Side effects of Tubitere Novo 20mg Injection:
- Breathlessness
- Constipation
- Edema (swelling)
- Infection
- Loss of appetite
- Muscle pain
- Nail disorder
- Pain
- Weakness
How to use Tubitere Novo 20mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
How Tubitere Novo 20mg Injection works:
Oncaspar 20mg injection is a cancer treatment that disrupts the microtubule networks essential for cancer cell division and proliferation. This action inhibits tumor growth and ultimately leads to cancer cell death.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while using Tubitere Novo 20mg Injection is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Administering Tubitere Novo 20mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. In exceptional circumstances involving life-threatening conditions, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is mandatory.
Breast feedingUNSAFE
Administration of Tubitere Novo 20mg Injection is contraindicated while breastfeeding due to potential infant toxicity.
DrivingCONSULT YOUR DOCTOR
Tubitere Novo 20mg Injection's effect on driving ability is undetermined. Refrain from driving if you exhibit symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
The injectable medication, Tubitere Novo 20mg, presents no safety concerns for patients with renal impairment; dosage modification is unnecessary.
LiverCAUTION
Patients with liver impairment should use Tubitere Novo 20mg Injection cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Tubitere Novo 20mg Injection :
NA
Facts to Know About Tubitere Novo 20mg Injection
| Label | Value |
|---|---|
| Type of Compound | Taxane-based agents |
| Addictive | None. |
| Medication Classification | Cancer therapies |
| Mechanism of Action | Microtubule-targeting drugs: Taxane class |
3,018 People bought this recently